Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Assets Average: 2024-2025

Historic Assets Average for Artiva Biotherapeutics (ARTV) over the last 1 years, with Sep 2025 value amounting to $159.1 million.

  • Artiva Biotherapeutics' Assets Average rose 5.55% to $159.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.1 million, marking a year-over-year increase of 5.55%. This contributed to the annual value of $157.3 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Artiva Biotherapeutics' Assets Average is $159.1 million, which was down 11.76% from $180.3 million recorded in Q2 2025.
  • In the past 5 years, Artiva Biotherapeutics' Assets Average ranged from a high of $217.6 million in Q4 2024 and a low of $150.8 million during Q3 2024.
  • For the 2-year period, Artiva Biotherapeutics' Assets Average averaged around $181.6 million, with its median value being $180.3 million (2025).
  • Data for Artiva Biotherapeutics' Assets Average shows a peak YoY increased of 5.55% (in 2025) over the last 5 years.
  • Artiva Biotherapeutics' Assets Average (Quarterly) stood at $217.6 million in 2024, then increased by 5.55% to $159.1 million in 2025.
  • Its Assets Average was $159.1 million in Q3 2025, compared to $180.3 million in Q2 2025 and $200.4 million in Q1 2025.